Pathophysiology of dyspnea in COPD

被引:59
作者
Anzueto, Antonio [1 ,2 ]
Miravitlles, Marc [3 ,4 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Pulmonol Sect, San Antonio, TX 78229 USA
[2] South Texas Vet Hlth Care Syst, Dept Med, Pulm Sect, San Antonio, TX USA
[3] Hosp Univ Vall dHebron, Pneumonol Dept, Barcelona, Spain
[4] CIBERES, Barcelona, Spain
关键词
COPD; dyspnea; lung; bronchodilator; OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC RESPIRATORY SYMPTOMS; PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; LUNG HYPERINFLATION; EXERCISE TOLERANCE; PHYSICAL-ACTIVITY; STABLE COPD; FLOW LIMITATION; INDACATEROL;
D O I
10.1080/00325481.2017.1301190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyspnea refers to the sensation of breathlessness, shortness of breath, or difficulty breathing that is commonly observed in patients with respiratory and cardiac disease. In the United States alone, dyspnea is reported in up to 4 million all-cause emergency room visits annually. Dyspnea can be a symptom of several different underlying physical conditions, typically involving the lung and heart. Indeed, it is an important symptom in chronic obstructive pulmonary disease (COPD), where it is associated with limited physical activity, increased anxiety and depression, decreased health-related quality of life (HRQoL), and reduced survival. Currently there is no single physiological correlate that will accurately predict dyspnea, particularly because the mechanisms that contribute to respiratory discomfort can vary between diseases and between individuals experiencing breathlessness who have been diagnosed with the same disease. Therefore, various subjective clinical and psychophysical scales and questionnaires are typically used to measure or predict dyspnea. It is the goal of this review to discuss the pathophysiological mechanisms leading to dyspnea, particularly those associated with COPD, the physical and psychological impact on patients, assessment approaches, and modalities currently used to treat it.
引用
收藏
页码:366 / 374
页数:9
相关论文
共 100 条
[41]   Symptom variability in patients with severe COPD: a pan-European cross-sectional study [J].
Kessler, R. ;
Partridge, M. R. ;
Miravitlles, M. ;
Cazzola, M. ;
Vogelmeier, C. ;
Leynaud, D. ;
Ostinelli, J. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) :264-272
[42]   Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction [J].
Kitaguchi, Yoshiaki ;
Fujimoto, Keisaku ;
Hanaoka, Masayuki ;
Honda, Takayuki ;
Hotta, Junichi ;
Hirayama, Jiro .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 :805-810
[43]   Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison [J].
Kornmann, O. ;
Dahl, R. ;
Centanni, S. ;
Dogra, A. ;
Owen, R. ;
Lassen, C. ;
Kramer, B. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) :273-279
[44]   Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1 [J].
Lahaije, Anke J. M. C. ;
van Helvoort, Hanneke A. C. ;
Dekhuijzen, P. N. Richard ;
Vercoulen, Jan H. ;
Heijdra, Yvonne F. .
RESPIRATORY MEDICINE, 2013, 107 (06) :834-840
[45]   Prevalence of night-time dyspnoea in COPD and its implications for prognosis [J].
Lange, Peter ;
Marott, Jacob Louis ;
Vestbo, Jorgen ;
Nordestgaard, Borge Gronne .
EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (06) :1590-1598
[46]   The multiple dimensions of dyspnea: Review and hypotheses [J].
Lansing, Robert W. ;
Gracely, Richard H. ;
Banzett, Robert B. .
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2009, 167 (01) :53-60
[47]   Recent Advances in Dyspnea [J].
Mahler, Donald A. ;
O'Donnell, Denis E. .
CHEST, 2015, 147 (01) :232-241
[48]   Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study [J].
Mahler, Donald A. ;
Decramer, Marc ;
D'Urzo, Anthony ;
Worth, Heinrich ;
White, Tracy ;
Alagappan, Vijay K. T. ;
Chen, Hungta ;
Gallagher, Nicola ;
Kulich, Karoly ;
Banerji, Donald .
EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (06) :1599-1609
[49]   Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease [J].
Mahler, Donald A. ;
Ward, Joseph ;
Waterman, Laurie A. ;
McCusker, Corliss ;
ZuWallack, Richard ;
Baird, John C. .
CHEST, 2009, 136 (06) :1473-1479
[50]   Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline [J].
Marciniuk, Darcy D. ;
Goodridge, Donna ;
Hernandez, Paul ;
Rocker, Graeme ;
Balter, Meyer ;
Bailey, Pat ;
Ford, Gordon ;
Bourbeau, Jean ;
O'Donnell, Denis E. ;
Maltais, Francois ;
Mularski, Richard A. ;
Cave, Andrew J. ;
Mayers, Irvin ;
Kennedy, Vicki ;
Oliver, Thomas K. ;
Brown, Candice .
CANADIAN RESPIRATORY JOURNAL, 2011, 18 (02) :69-78